Pebble Biotechnology Laboratories Ltd is a private limited company situated at 122, Beech Court Hollin Lane, Styal, Wilmslow SK9 4LD. Its total net worth is valued to be 0 pounds, while the fixed assets belonging to the company amount to 0 pounds. Incorporated on 2018-03-27, this 6-year-old company is run by 4 directors.
Director Anthony F., appointed on 01 November 2022. Director Douglas S., appointed on 22 July 2021. Director Mark C., appointed on 22 July 2021.
The company is officially categorised as "research and experimental development on biotechnology" (SIC code: 72110). According to CH data there was a change of name on 2022-11-03 and their previous name was Perfusion Biotechnology Ltd.
The latest confirmation statement was sent on 2023-03-26 and the date for the following filing is 2024-04-09. What is more, the accounts were filed on 31 March 2022 and the next filing should be sent on 31 December 2023.
| Office Address | 122, Beech Court Hollin Lane |
| Office Address2 | Styal |
| Town | Wilmslow |
| Post code | SK9 4LD |
| Country of origin | United Kingdom |
| Registration Number | 11278041 |
| Date of Incorporation | Tue, 27th Mar 2018 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st March |
| Company age | 6 years old |
| Account next due date | Sun, 31st Dec 2023 (117 days after) |
| Account last made up date | Thu, 31st Mar 2022 |
| Next confirmation statement due date | Tue, 9th Apr 2024 (2024-04-09) |
| Last confirmation statement dated | Sun, 26th Mar 2023 |
Position: Director
Appointed: 01 November 2022
Position: Director
Appointed: 22 July 2021
Position: Director
Appointed: 22 July 2021
Position: Director
Appointed: 27 March 2018
The list of PSCs that own or control the company is made up of 1 name. As BizStats discovered, there is James F. The abovementioned PSC has 50,01-75% voting rights and has 50,01-75% shares.
James F.
| Notified on | 27 March 2018 |
| Nature of control: |
50,01-75% shares 50,01-75% voting rights right to appoint and remove directors |
| Perfusion Biotechnology | November 3, 2022 |
| Perfusion Research | June 21, 2021 |
| Profit & Loss | |||||
|---|---|---|---|---|---|
| Accounts Information Date | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
| Balance Sheet | |||||
| Cash Bank On Hand | 1 322 | 152 842 | 90 962 | ||
| Current Assets | 13 047 | 3 495 | 1 334 | 206 322 | 309 387 |
| Debtors | 12 | 53 480 | 218 425 | ||
| Net Assets Liabilities | 11 967 | 3 135 | |||
| Other Debtors | 23 274 | ||||
| Property Plant Equipment | 1 628 | 14 269 | |||
| Other | |||||
| Accrued Liabilities Deferred Income | 5 541 | 92 257 | |||
| Accrued Liabilities Not Expressed Within Creditors Subtotal | -1 080 | -360 | |||
| Accumulated Depreciation Impairment Property Plant Equipment | 255 | 2 829 | |||
| Additions Other Than Through Business Combinations Property Plant Equipment | 1 883 | 15 215 | |||
| Average Number Employees During Period | 3 | 4 | 1 | 3 | 8 |
| Called Up Share Capital Not Paid | 12 | 3 | 3 | ||
| Corporation Tax Payable | -4 | ||||
| Corporation Tax Recoverable | 15 089 | 62 004 | |||
| Creditors | -4 | 43 671 | 194 558 | ||
| Future Minimum Lease Payments Under Non-cancellable Operating Leases | 9 687 | 28 958 | |||
| Increase From Depreciation Charge For Year Property Plant Equipment | 255 | 2 574 | |||
| Net Current Assets Liabilities | 1 338 | 162 651 | 114 829 | ||
| Other Creditors | 873 | 2 606 | |||
| Other Taxation Social Security Payable | 12 734 | 5 484 | |||
| Prepayments Accrued Income | 8 643 | 103 142 | |||
| Property Plant Equipment Gross Cost | 1 883 | 17 098 | |||
| Total Assets Less Current Liabilities | 1 338 | 164 279 | 129 098 | ||
| Trade Creditors Trade Payables | 24 523 | 94 211 | |||
| Trade Debtors Trade Receivables | 29 745 | 30 002 | |||
| Type | Category | Free download | |
|---|---|---|---|
| AA |
Total exemption full accounts data made up to 31st March 2023 filed on: 21st, December 2023 |
accounts | Free Download (10 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy